Persistent Subretinal Fluid: Wait or Treat?

Key Findings & Data:This report is a description of steroid treatment used in the case of a 46-year-old male patient with SRF persisting for 15 months after pars plana vitrectomy surgery for the treatment of macula-off RRD.

💡

Conclusion & Impact:It was concluded that an IVTA injection should be used in a limited fashion in patients with persistent SRF.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Özet

Persistent subretinal fluid (SRF) may occur even after successful surgery for rhegmatogenous retinal detachment (RRD). In most cases, persistent SRF resolves spontaneously within a year, but persistent SRF may cause poor central vision, photoreceptor damage, and the irreversible loss of visual function. Therefore, a variety of interventions have been developed to manage persistent SRF, including the prophylactic use of steroids. As far as we know, an intravitreal steroid injection has never been used in the treatment of persistent SR. This report is a description of steroid treatment used in the case of a 46-year-old male patient with SRF persisting for 15 months after pars plana vitrectomy surgery for the treatment of macula-off RRD. A single-dose intravitreal triamcinolone acetonide (IVTA) injection (4 mg/0.1 mL) was administered; however, no improvement was seen in the lesions. It was concluded that an IVTA injection should be used in a limited fashion in patients with persistent SRF.

🔖

Cite This Article

YASSA, E. T., BAKBAK, B. (2018). Persistent Subretinal Fluid: Wait or Treat?. BEYOGLU EYE JOURNAL, Cilt: 3 - Sayı: 2, 99–100. https://ajindex.com/articles/145787

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Kim JM, Lee EJ, Cho GE, Bae K, Lee JY, Han G, et al. Delayed Absorption of Subretinal Fluid after Retinal Reattachment Surgery and Associated Choroidal Features. Korean J Opthalmol 2017;31:402–11. [CrossRef] Hagimura N, Iida T, Suto K, Kishi S. Persistent foveal retinal detachment after successful rhegmatogenous retinal detachment surgery. Am J Ophthalmol 2002;133:516–20. [CrossRef] Kim YK, Ahn J, Woo SJ, Hwang DJ, Park KH. Multiple subretinal fluid blebs after successful retinal detachment surgery: incidence, risk factors, and presumed pathophysiology. Am J Ophthalmol 2014;157:834–41. [CrossRef] Kang SW, Kim JH, Shin WJ, Kim JI. Subretinal fluid bleb after successful scleral buckling and cryotherapy for retinal detachment. Am J Ophthalmol 2008;146:205–10. [CrossRef] Ricker LJ, Noordzij LJ, Goezinne F, Cals DW, Berendschot TT, Liem AT, et al. Persistent subfoveal fluid and increased preoperative foveal thickness impair visual outcome after maculaoff retinal detachment repair. Retina 2011;31:1505–12. [CrossRef] Veckeneer M, Derycke L, Lindstedt EW, van Meurs J, Cornelissen M, Bracke M, Van Aken E. Persistent subretinal fluid after surgery for rhegmatogenous retinal detachment: hypothesis and review. Graefes Arch Clin Exp Ophthalmol 2012;250:795– 802. [CrossRef] Koinzer S, Elsner H, Klatt C, Pörksen E, Brinkman R, Birngruber R, et al. Selective retina therapy (SRT) of chronic subfoveal fluid after surgery of rhegmatogenous retinal detachment: three case reports. Graefes Arch Clin Exp Ophthalmol 2008;246:1373–8. [CrossRef] Itakura H, Kishi S. Intravitreal injection of 0.3 ml of SF6 gas for persistent subfoveal fluid after scleral buckling for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 2009;247:1147–50. [CrossRef] Wu JS, Lin CJ, Hwang JF, Chen SN. Influence of systemic steroids on subretinal fluid after scleral buckle surgery for maculaoff retinal detachment. Retina 2011;31:99–104. [CrossRef] Mirsahi A, Karkhaneh R, Zamani Amir J, Movassat M, Azadi P. Influence of intravitreal triamcinolone acetonide injection in scleral buckling surgery for macula-off retinal detachment. Ophthalmic Res 2014;52:160–4. [CrossRef]